US Patent Issued to Natera on Sept. 22 for "Systems and methods for determining aneuploidy risk using sample fetal fraction" (California, New York Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,744,126, issued on Sept. 22, was assigned to Natera Inc. (San Carlos, Calif.).

"Systems and methods for determining aneuploidy risk using sample fetal fraction" was invented by Allison Ryan (Belmont, Calif.), Katie Kobara (San Francisco), Zachary Demko (San Francisco) and Susan J. Gross (Bronx, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are system, method, and computer program product embodiments for determining aneuploidy risk in a target sample of maternal blood or plasma based on the amount of fetal DNA. An embodiment operates by receiving known genetic data from known prenatal testing samples and genetic data for the targe...